The Latin America, Middle East and Africa Transcatheter Aortic Valve Replacement Market would witness market growth of 13.9% CAGR during the forecast period (2022-2028).
Manufacturers are concentrating on R&D cutting-edge and affordable valve replacement systems to enhance their market share. The need for AVR devices is driven by the increased prevalence of AS and valvular disorders, as these ailments can potentially cause fatal consequences such as heart failure and stroke. To stop the course of these illnesses and lower the risk of consequences, early diagnosis and treatment are essential.
As a result, the market share for aortic valve replacement devices is being driven by a rise in awareness regarding the significance of early identification and treatment of AS and valvular illnesses. According to numerous studies, TAVR devices are just as efficient as surgical aortic valve replacement devices, offering them a more appealing choice for patients and medical professionals. Moreover, favorable funding practices in several nations have aided in the uptake of TAVR devices and increased patient access to them.
The World Bank 2012 report estimates that 4.7% of the 336 million people in the Middle East and Northern Africa (MENA) are over 65. According to Statistics South Africa's most recent mid-year population forecasts, the estimated population of South Africa is 56.5 million people. In addition, the senior population in South Africa—defined as those who are 60 and older—grew to 8.1% in 2017. 4.6 million persons in South Africa are over the age of 60. 7.7% of the population is over 65; however, in Gauteng, they account for roughly 25% of the population. Less than 12% of the elderly reside in the Eastern Cape, where geriatrics comprise about 10% of the population.
The Brazil market dominated the LAMEA Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $171.1 million by 2028. The Argentina market is experiencing a CAGR of 14.5% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 13.6% during (2022 - 2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Transcatheter Aortic Valve Replacement Market is Predict to reach $8 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
By Material
By Implantation Procedure
By Mechanism
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
